Kaleido Biosciences (KLDO) Short Interest Ratio & Short Volume $0.0001 0.00 (0.00%) As of 02:15 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Kaleido Biosciences Short Interest DataKaleido Biosciences (KLDO) has a short interest of 67,200 shares, representing 0.17% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 30.5, indicating that it would take 30.5 days of the average trading volume of 9,185 shares to cover all short positions.Current Short Interest67,200 sharesPrevious Short Interest67,200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$6.72Short Interest Ratio30.5 Days to CoverLast Record DateMay 31, 2025Outstanding Shares42,623,000 sharesShort Percent of Float0.17%Today's Trading Volume2,216 sharesAverage Trading Volume9,185 sharesToday's Volume Vs. Average24% Short Selling Kaleido Biosciences? Sign up to receive the latest short interest report for Kaleido Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKLDO Short Interest Over TimeKLDO Days to Cover Over TimeKLDO Percentage of Float Shorted Over Time Kaleido Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202567,200 shares $6.72 No Change0.2%30.5 $0.00 5/15/202567,200 shares $13.44 +2.9%N/A168 $0.00 4/30/202565,300 shares $6.53 No ChangeN/A93.3 $0.00 4/15/202565,300 shares $6.53 No ChangeN/A15.2 $0.00 3/14/202565,300 shares $6.53 No ChangeN/A93.3 $0.00 2/14/202565,300 shares $0.00 No ChangeN/A0 $0.00 1/31/202565,300 shares $0.00 No ChangeN/A653 $0.00 1/15/202565,300 shares $0.00 No ChangeN/A326.5 $0.00 4/15/20221,400,000 shares $406 thousand -40.2%7.3%0.3 $0.29 3/31/20222,340,000 shares $3.86 million +0.4%12.2%3.9 $1.65 Get the Latest News and Ratings for KLDO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kaleido Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/15/20222,330,000 shares $3.24 million +7.9%12.2%19.8 $1.39 2/28/20222,160,000 shares $3.22 million +3.4%11.3%16.5 $1.49 2/15/20222,090,000 shares $3.39 million +7.7%10.9%15.3 $1.62 1/31/20221,940,000 shares $3.41 million -5.4%10.1%13.4 $1.76 1/15/20222,050,000 shares $4.53 million -4.2%10.7%14.6 $2.21 12/31/20212,140,000 shares $5.11 million -3.2%11.2%15.3 $2.39 12/15/20212,210,000 shares $6.81 million -5.2%11.5%15.2 $3.08 11/30/20212,330,000 shares $8.36 million +5.9%12.2%16.9 $3.59 11/15/20212,200,000 shares $10.34 million +2.8%11.5%17 $4.70 10/29/20212,140,000 shares $9.20 million -4.0%11.2%17 $4.30 10/15/20212,230,000 shares $11.02 million -15.2%11.6%17.4 $4.94 9/30/20212,630,000 shares $14.36 million -0.8%13.7%18.4 $5.46 9/15/20212,650,000 shares $14.26 million +2.7%13.8%10.9 $5.38 8/31/20212,580,000 shares $15.84 million -21.1%13.5%10.3 $6.14 8/13/20213,270,000 shares $20.08 million -7.9%17.1%12.7 $6.14 7/30/20213,550,000 shares $19.28 million +2.6%18.6%13.4 $5.43 7/15/20213,460,000 shares $23.77 million +1.2%18.1%12.4 $6.87 6/30/20213,420,000 shares $25.44 million +0.9%17.9%10.1 $7.44 6/15/20213,390,000 shares $22.27 million +0.3%17.8%9.6 $6.57 5/28/20213,380,000 shares $24.27 million +1.8%17.7%12.6 $7.18 5/14/20213,320,000 shares $19.32 million +2.2%17.4%11.6 $5.82 4/30/20213,250,000 shares $26.16 million +7.3%17.0%9.9 $8.05 4/15/20213,030,000 shares $20.82 million +7.8%15.9%8 $6.87 3/31/20212,810,000 shares $20.40 million +11.5%15.3%9.1 $7.26 3/15/20212,520,000 shares $25.28 million -3.1%13.7%9.1 $10.03 2/26/20212,600,000 shares $24.93 million -5.8%17.8%10 $9.59 2/12/20212,760,000 shares $33.62 million -15.9%19.4%11.7 $12.18 1/29/20213,280,000 shares $55.17 million -2.4%22.7%16.1 $16.82 1/15/20213,360,000 shares $43.95 million +1.5%26.6%25.5 $13.08 12/31/20203,310,000 shares $31.78 million +12.2%26.2%24.1 $9.60A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 12/15/20202,950,000 shares $28.85 million -15.2%23.3%11.1 $9.78 11/30/20203,480,000 shares $26.52 million +3.0%27.5%13.3 $7.62 11/15/20203,380,000 shares $24.17 million +4.6%27.4%12.7 $7.15 10/30/20203,230,000 shares $20.32 million +6.3%26.2%11.9 $6.29 10/15/20203,040,000 shares $29.40 million +10.6%24.9%11 $9.67 9/30/20202,750,000 shares $30.44 million +15.1%22.5%10.1 $11.07 9/15/20202,390,000 shares $14.05 million +3.9%19.6%11.1 $5.88 8/31/20202,300,000 shares $14.47 million -1.3%18.9%15.4 $6.29 8/14/20202,330,000 shares $18.41 million +0.9%19.4%12.7 $7.90 7/31/20202,310,000 shares $13.79 million +7.9%21.3%13 $5.97 7/15/20202,140,000 shares $13.18 million -5.7%19.7%12.8 $6.16 6/30/20202,270,000 shares $16.75 million +35.1%29.1%14.4 $7.38 KLDO Short Interest - Frequently Asked Questions What is Kaleido Biosciences' current short interest? Short interest is the volume of Kaleido Biosciences shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 67,200 shares of KLDO short. 0.17% of Kaleido Biosciences' shares are currently sold short. Learn More on Kaleido Biosciences' current short interest. What is a good short interest ratio for Kaleido Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KLDO shares currently have a short interest ratio of 30.0. Learn More on Kaleido Biosciences's short interest ratio. What is a good short interest percentage for Kaleido Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of Kaleido Biosciences' floating shares are currently sold short. How does Kaleido Biosciences' short interest compare to its competitors? 0.17% of Kaleido Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "computer software" compare to Kaleido Biosciences: Zapata Computing Holdings Inc. (0.58%), Presto Automation Inc. (0.00%), Grom Social Enterprises, Inc. (0.00%), Kubient, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Kaleido Biosciences stock? Short selling KLDO is an investing strategy that aims to generate trading profit from Kaleido Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kaleido Biosciences? A short squeeze for Kaleido Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KLDO, which in turn drives the price of the stock up even further. How often is Kaleido Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KLDO, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Zapata Computing Short Interest Data Presto Automation Short Interest Data Grom Social Enterprises Short Interest Data Kubient Short Interest Data AppTech Payments Short Interest Data Arbe Robotics Short Interest Data Arogo Capital Acquisition Short Interest Data Aurora Innovation Short Interest Data Bannix Acquisition Short Interest Data Canna-Global Acquisition Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KLDO) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored"I'm risking my reputation on this"Crypto book predicted the last bull run (get it FREE now) This newly updated edition contains everything we...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.